Robert Francomano

Chief Commercial Officer, STEMLINE THERAPEUTICS INC.

Companies

Galena BiopharmaChief Commercial Officer Mar 14, 2022 to Jan 25, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Galena Biopharma SLS40,918 shares²$434.9K at $10.63Jan 22, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 22, 2024Granted 20,000 shares of Galena Biopharma²
Dec 6, 2023Other 1,082 shares at $1.08 of Galena Biopharma³
Feb 2, 2023Granted 12,000 shares of Galena Biopharma⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARGalena Biopharma, Chief Commercial Officer
2
SEC EDGARGalena Biopharma shares after the filing of Jan 22, 2024
3
SEC EDGARForm 4 filed Dec 8, 2023
4
SEC EDGARForm 4 filed Feb 3, 2023